INTRODUCTION
============

Treating peripheral vascular disease with endovascular procedures is a rapidly expanding field in the medical practice. Percutaneous transluminal angioplasty (PTA) reduces luminal stenosis by breaking plaques and expanding the disease-free portion of the arterial wall. The corresponding injury involves endothelial exposure and intimomedial tears.[@b1-cln63_2p0229] Although balloon angioplasty provides good results, both acutely and chronically, stents are being more frequently used to improve patency.[@b2-cln63_2p0229],[@b3-cln63_2p0229]

Since the placement of the first intravascular stent in 1985 by Palmaz, stenting has become an effective procedure to treat large-caliber vessel stenosis.[@b2-cln63_2p0229] However; stenting is still considered a controversial procedure. While stenting is considered acceptable for aortoiliac vessels, it is still questionable for the femoropopliteal or more distal vasculature.[@b3-cln63_2p0229] In recent years, nitinol has become the preferred metal alloy for making stents because of its thermoreactive shape-memory characteristics,[@b3-cln63_2p0229] which provide both flexibility and self-expandability.

Restenosis of treated vessels is one of the causes of clinical symptom recurrence after revascularization, and it is a common limitation of endovascular procedures, with a restenosis recurrence rate of 30--40% within three to six months. Acute restenosis is often the result of wall spasm, in situ thrombosis, or elastic recoil. Intimal hyperplasia is an important key factor in chronic restenosis[@b1-cln63_2p0229],[@b4-cln63_2p0229] and promotes in-stent restenosis. In contrast to atherosclerosis, smooth muscle cell migration and intimal proliferation are critical early events in intimal hyperplasia. The main process (proliferation and migration) is completed in pigs after 28 days, while in humans cellular proliferation reaches its maximum by three to six months without further progression.[@b1-cln63_2p0229],[@b11-cln63_2p0229],[@b12-cln63_2p0229] The neointima is similar to that observed in humans with respect to cell size, cell density, and histological presentation.[@b2-cln63_2p0229],[@b4-cln63_2p0229],[@b12-cln63_2p0229]

Important atherosclerosis risk factors were described in the Framingham study and have been further expanded and elucidated.[@b5-cln63_2p0229] These risk factors include hyperlipidemia, hypertension, and diabetes, along with epidemiologic factors such as smoking, diet, stress and family history.[@b5-cln63_2p0229],[@b6-cln63_2p0229] The theory that homocysteine could contribute to atherosclerosis was first proposed by McCully & Wilson in 1975.[@b18-cln63_2p0229] In addition to favoring atheromatous plaque formation in elastic and muscular arteries, it can also cause both arterial and venous thrombosis, affecting vessels of any diameter. It is still uncertain whether normalizing or lowering plasma homocysteine levels impacts the incidence and development of vascular diseases.[@b19-cln63_2p0229] In fact, high homocysteine levels causes peripheral arterial disease.[@b7-cln63_2p0229] Patients with hyperhomocysteinemia have pre-existing intimal hyperplasia in saphenous vein biopsies, an increasing rate of vein graft stenosis and increased bypass graft failure.[@b8-cln63_2p0229] Hyperhomocysteinemia may also be associated with accelerated disease progression.[@b8-cln63_2p0229],[@b9-cln63_2p0229] However, the effects of hyperhomocysteinemia on endovascular procedures are unknown.

Research in endovascular surgery is constantly evolving. Early studies focused on the morphology, physiology, and pathogenesis of reactions occurring after stent placement. Experimenting with more suitable animal models has been a constant goal and motive of much debate.[@b2-cln63_2p0229],[@b11-cln63_2p0229] In humans, endovascular procedures are performed in atherosclerotic arteries with large amounts of plaque, while the same procedures are used to create injuries in normal, disease-free vessels in animal models in most experiments. As a result, the contributing factors of restenosis may be different, which would explain why many therapeutic strategies in clinical trials fail.[@b2-cln63_2p0229],[@b11-cln63_2p0229] Swine and primates best meet the requirements of a restenosis model and develop lesions that are physiologically and morphologically similar to humans.[@b11-cln63_2p0229] We hypothesize that intimal hyperplasia in homocysteinemic pigs arteries may be greater than in normal pigs after stent deployment. The purpose of this study was to evaluate and compare aortic intimal thickening of normal and hyperhomocysteinemic pigs using digital morphometry after the placement of self-expanding nitinol stents.

MATERIAL AND METHODS
====================

The study was approved by the Ethical Committee for the Post Graduation Group at Hospital de Clínicas de Porto Alegre, Brazil. The experiment was conducted in the Research Center facilities of the referred hospital. Nitinol stents were manufactured by the Mechanical Transformation Lab of the Engineering School of the Federal University of Rio Grande do Sul (Laboratório de Transformação Mecânica da Escola de Engenharia da Universidade Federal do Rio Grande do Sul) based on ELLA-CS^®^, Dr. Varel Volenec's stent patterns. Those stents were self-expandable, 25 mm in length and 8 mm in expanded diameter, ethylene-oxide cleansed, and sterilized.

Eighteen Macau pigs were used in the study, all over eight weeks of age with an average weight of 30 kg. Pigs were randomized into two groups. Each group was kept separately and labeled as Group C (control group) and Group M (methionine group). Pigs in group C were given standard pig chow and drinking water *ad libitum*. Pigs in group M were fed the same chow plus 3% methionine for 30 days before the day of surgery; methionine supplementation was then discontinued. The aim of this study was to promote arterial lesions prior to the endovascular procedure. Animal models are difficult to obtain because they require long maintenance periods of hyperlipemic diets administered to specific genetic breeds.[@b11-cln63_2p0229],[@b12-cln63_2p0229] To avoid such problems and promote early atherosclerosis in pigs, we used a 30-day methionine--rich diet to promote arterial lesions. These lesions were similar to those previously described by Rolland et al,[@b13-cln63_2p0229] and we have previously shown that a 30-day methionine--rich diet consistently promotes homocysteine arterial lesions in pig iliac arteries[@b21-cln63_2p0229] and rabbit aortas.[@b20-cln63_2p0229]

Blood samples were collected at day 0, 30 and 60 to determine total cholesterol, triglycerides, HDL, and homocysteine concentrations. Total cholesterol, triglycerides and HDL analyses were performed by enzymatic-colorimetric methods. Homocysteine was determined by HPLC (high performance liquid chromatography). Homocysteine levels were measured at the onset of the methionine supplementation (30 days prior to surgery), on the day of surgery, and 30 days after surgery.

Exclusion criteria included animal death before the time established for tissue collection, surgical complications during or after surgery, and technical failures of tissue preparation or processing.

Surgical procedures
-------------------

The surgical procedure was performed at 30 days. Anesthesia was induced by an intramuscular injection of xylazine. Prior to endotracheal intubation, anesthesia was increased by intravenous ketamine injection, which was followed by orotracheal intubation and volume-controlled ventilation using 1.5% isoflurane. No oral anticoagulant or antiplatelet therapy was used in the follow-up period to facilitate neointimal formation. Postoperative pain management included intramuscular administration of Tramal (tramadol) and Dipirona (dipyrone). Antibiotic prophylaxis with IV cefazolin was administered on the day of surgery. After sterile preparation, the carotid artery was dissected through an oblique cervical incision, and a 7F sheath and 0.035 stiff guidewire were introduced. All animals received IV heparin (5000U) after the carotid sheaths were inserted. The stents were then deployed at the infra-renal abdominal aorta. After stent placement, angiography was performed, the carotid access site was ligated, and the surgical wound was closed with resorbable sutures. Thirty days after the procedure, follow-up angiography and animal sacrifice was performed (at 60 day), and the abdominal aorta segment was removed for histological and digital morphometry analysis.

Histological analysis
---------------------

The infra-renal portion of the aorta was removed and irrigated with a 0.9% sodium chloride solution, and vessel patency was checked macroscopically. Specimens were cut longitudinally in the segment containing the stent, and transverse sections were obtained. All sections were fixed in 10% formaldehyde. Transverse sections from the stent's mid-part were removed for morphometric analysis. Segments were processed, set in paraffin blocks and later sectioned at 4 μm for display on the microscope slides. Slides were then prepared and stained with hematoxylin and eosin.

Morphometric analysis
---------------------

Quantification methodology was employed to determine intimal thickening of the stents using digital morphometric analysis based on an integrated morphometric program and image analysis (Media Cybernetics: Image Pro Plus). Histological sections were digitalized for morphometric analysis by conventional optical microscopy (Zeiss Microscope, Axiastar Model), achromatic optical plane and photo-storage tube (Sony® DXC 151 Video Camera), which generated image files in a PC. Images were digitalized with a 100-magnification microscope, and the intimal and medial areas were delimited, respectively, for the internal elastic membrane and endothelium. Area dimensions were described in mm^2^, using the average of eight microscopic fields. The external and internal elastic membranes defined the medial area, while the area limited by the internal elastic membrane and the endothelium was considered the intimal area. The pathologist was blinded to the group in which each animal belonged. Results were expressed as the median (interquartile range, IQR). Mann-Whitney's and Friedman's tests were used for statistical analysis between groups. Significance level was set at *p* \< 0.05.

RESULTS
=======

Eighteen animals were initially included in the study. All except four recovered fully between procedures. Two died of myocardial ischemia, one died from carotid artery rupture during the procedure, and the last animal was sacrificed because of paraplegia secondary to an occluded stent 24 hours after deployment. These four animals were excluded from the study. All stents placed in the remaining fourteen animals were patent immediately after deployment and remained this way until the follow-up angiography was performed ([Figure 1](#f1-cln63_2p0229){ref-type="fig"}). All animals remained clinically healthy until sacrifice.

Macroscopic evaluation of abdominal aorta specimens demonstrated that the stents were firmly attached to the aortic wall and covered by a thin, translucent cover in Group M ([Figure 2](#f2-cln63_2p0229){ref-type="fig"}). In Group C, the aortic wall was extensively covered on the luminal surface ([Figure 3](#f3-cln63_2p0229){ref-type="fig"}). Extensive intimal hyperplasia with no endothelial deposits and a well-defined internal elastic lamina was observed upon histological evaluation of the aortas in Group C ([Figure 4](#f4-cln63_2p0229){ref-type="fig"}). The abdominal aorta in Group M showed modified endothelial cells, and the intima was formed by foam macrophages and hypertrophic smooth muscle cells, without cholesterol crystals ([Figure 5](#f5-cln63_2p0229){ref-type="fig"}). There was elastic lamina disruption and smooth muscle cell hyperplasia, which are both characteristics of homocysteine-induced lesions. Comparing intimal thickening among the groups showed a pronounced intimal hyperplasia in group C as compared to group M, with a significant difference between groups (*p*=0.0041). Results are shown in [table 1](#t1-cln63_2p0229){ref-type="table"}.

Biochemical analysis
--------------------

Total cholesterol, HDL and triglyceride levels in plasma were analyzed, and no significant difference was observed between the two groups, which suggested that they had no influence on the final results (results are show in [tables 2](#t2-cln63_2p0229){ref-type="table"}, [3](#t3-cln63_2p0229){ref-type="table"} and [4](#t4-cln63_2p0229){ref-type="table"}).

Normal plasma homocysteine levels for animal experiments have not been established. We considered the average plasma homocysteine levels in Group C to be normal, and we compared plasma homocysteine levels in Group M to Group C. In Group C, there was no change in homocysteine levels during the eight-week-study (average values: 14.40 μmol/l on day 0; 16.73 μmol/l on day 30; 16.47 μmol/l on day 60). In group M, the average value for plasma homocysteine levels was 17.47 μmol/l on day 0, 59.80 μmol/l on day 30, and 32.74 μmol/l on day 60 ([table 5](#t5-cln63_2p0229){ref-type="table"}). Thus, plasma homocysteine in Group M reached a level approximately three times higher than Group C during the 30-day period before surgery. Although significant hyperhomocysteinemia (*p* = 0.0006) was detectable after 1 month in group M, the levels of homocysteine stabilized after two months in both groups.

DISCUSSION
==========

In the present study, the pig model was selected for two main reasons. First, swine models can be easily manipulated to mimic human vascular disease by atherogenic diets, and they display a remarkable similarity in lesion distribution, pathogenesis and morphology with those of humans.[@b12-cln63_2p0229] The pig's arterial system is prone to hypercoagulability, and their fibrinolytic system is not as active as the canine model. The coagulation system may be a relevant factor in neointimal hyperplasia and restenosis after balloon dilation and stent placement.[@b2-cln63_2p0229],[@b12-cln63_2p0229] Second, experiments with sulfur amino acid metabolism in this species more closely resemble the results obtained in humans. Additionally, it has previously been demonstrated that pigs fed with a methionine-rich diet for 30 days develop hyperhomocysteinemia, thrombotic events, and arterial lesions similar to those in patients with homo-cystinuria.[@b13-cln63_2p0229]

The plasma homocysteine concentrations recorded in our study ranged from 17.47 to 59.80 μmol/L, which are of similar levels to those observed in patients with hyperhomocysteinemia and are thought to contribute to premature vascular disease.[@b7-cln63_2p0229]--[@b9-cln63_2p0229],[@b18-cln63_2p0229] In addition, hyperhomocysteinemia developed in animals without significant changes in the serum lipid profile, which suggests that there was no interference from hypercholesterolemia. Our findings reproduce the situation encountered in young homocysteinemic patients, whose serum lipid profiles usually do not reveal hypercholesterolemia and in whom artherosclerotic lesions contain little or no evidence of accumulated lipid cores. The present study results in experimental hyperhomocysteinemic pigs are in accordance with the conclusions that homocysteinemia could represent a nonlipid model for artherosclerosis initiation.

With respect to homocysteine toxicity against vascular cells, it is possible that priming vascular cells with homocysteine results in the release of cytokines and/or growth factors by injured cells, as is the case after balloon-induced vascular injury. Specifically, smooth muscle cell activation and replication in the media may be driven by basic fibroblast growth factor released by injured medial cells, although other unknown growth factors may also be involved. The similarities between homocysteine and balloon injury-induced vascular wall alterations will serve as a framework for a working hypothesis to elucidate the mechanisms that account for the vascular consequences of hyperhomocysteinemia.^13\ 19,24^

A pig's abdominal aorta has positive features that make it suitable for experimentation, such as size and high flow. The pig aortas used in our experiment were, on average, 8 mm in diameter. There are advantages in handling a vessel of such diameter when implanting stents because arteries with a high flow are less likely to present with thrombosis, whereas stents implanted in low flow arteries are more prone to intimal hyperplasia.[@b25-cln63_2p0229]

Although stents may prevent elastic retraction by means of positive geometric remodeling, they are not immune to causing harm to the vascular system. Stents can be related to thrombus formation, higher inflammatory reaction, and neointimal thickening because the endothelial lesion exposes the subintimal elements, resulting in a cicatricial answer to injury.[@b1-cln63_2p0229] The reason we chose nitinol stents is related to their good biocompatibility, with minimal thrombus deposition or inflammatory response.[@b2-cln63_2p0229]

There are some differences between self-expanding and balloon-expanded stents, and their specific properties may affect the outcomes of experimental research. Mangell studied stent/vessel interaction and distensibility following the natural increase in vascular diameter using self-expanding and balloon-expanded stents in a swine model and concluded that balloon-expanded stents have no pulsatile movement and may detach when the vessel diameter increases.[@b14-cln63_2p0229] Harnek found that insertion of a self-expandable nitinol stent without previous PTA results in less intimal hyperplasia than if PTA is performed prior to stenting; this suggests that direct stenting can be used in angioplasty sessions with a favorable outcome.[@b16-cln63_2p0229] Sullivan found that maintaining an intact internal elastic lamina is an important factor for prevention of intimal hyperplasia and restenosis in stented iliac arteries.[@b17-cln63_2p0229] Based on these results; we chose to implant self-expanding stent without previous PTA in our study.

Intimal hyperplasia is the key point in this study. Schwartz states that the phases of neointimal formation in the pig may be similar to humans.[@b25-cln63_2p0229],[@b26-cln63_2p0229] The major limitation of animal models is the lack of pre-existing disease in the vascular wall, like atherosclerosis in humans.[@b11-cln63_2p0229] However, the findings related to intimal hyperplasia after stent implantation in experimental animals maintained on an atherogenic diet were not different when comparing normal and stenotic arteries.[@b11-cln63_2p0229],[@b25-cln63_2p0229],[@b26-cln63_2p0229] Obtaining histological slices four weeks after stents were added seems to be sufficient for intimal thickening studies. In the pig model, the reaction to a lesion led to the formation of neointimal hyperplasia in one or two weeks and the process was complete within twenty-eight days. In terms of histology, size, and cellular density, this process is similar to what occurs in humans.[@b1-cln63_2p0229],[@b4-cln63_2p0229],[@b11-cln63_2p0229]--[@b14-cln63_2p0229] After implanting stents in the iliac and carotid arteries of pigs, Verheye et al. conducted histological studies one to six months after implantation and stated that the vascular wall was completely covered by endothelial-type cells within one month.[@b27-cln63_2p0229] Similar to these authors, we studied intimal thickening of the vessel wall 30 days after stent implantation to analyze arterial wall alterations. Smet et al. studied the amount of neointima found after stent placement in pre-existent plaque mass in the peripheral arteries of micropigs. Plaque formation was achieved after exposure to diet-induced atherosclerosis. They concluded that the amount of plaque present before stent placement was a determinant of the amount of intimal hyperplasia present after stent placement.[@b15-cln63_2p0229] In contrast, existing lesions caused by hyperhomocysteinemia did not enhance intimal hyperplasia in the present study.

The relationship between hyperhomocysteinemia and restenosis after peripheral vascular intervention remains controversial; some studies have attempted to elucidate several potential mechanisms by which hyperhomocysteinemia may stimulate myointimal hyperplasia.[@b19-cln63_2p0229], [@b23-cln63_2p0229], [@b24-cln63_2p0229] Laxdal et al. investigated the relationship between plasma homocysteine and other haemostatic variables, and restenosis or reocclusion after endovascular treatment of symptomatic atherosclerosis of the femoropopliteal artery above the knee. In these studies, they found that plasma homocysteine did not appear to influence endovascular intervention outcomes.[@b22-cln63_2p0229] After comparing the morphology of the muscular femoral artery in atherosclerosis and hyperhomocysteinemic patients to atherosclerotic vessels from normal homocysteine level patients, Vermeulen et al. concluded that hyperhomocysteinemia is associated with a significant decrease in the smooth muscle cell/extracellular matrix ratio of the medial layer of the muscular femoral arteries, without significant changes in medial thickness.[@b23-cln63_2p0229] On the other hand, the effects of elevated plasma homocysteine responses in the peripheral vascular bed, after stent placement, have not been reported. In our study, aside from preexisting lesions caused by hyperhomocysteinemia, no significant intimal hyperplasia was observed. This was an unexpected result, and we believe that some therapeutic effects of homocysteine on restenosis after stent deployment will be elucidated with further research. This is the first report of a hyperhomocysteinemia and intimal hyperplasia experimental model after stent placement in pig aortas. We can only speculate on our findings; perhaps, as Vermeulen et al. concluded, a mechanism exists that lowers the smooth muscle cell/extracellular matrix ratio. Further studies are required to better understand these findings.

CONCLUSION
==========

Insertion of self-expandable nitinol stent in pig aortas after 30 days on a methionine-rich diet results in less intimal hyperplasia than is found in normal pigs.
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![Angiography after stent deployment in pig aorta](cln63_2p0229f1){#f1-cln63_2p0229}

![Macroscopic view of stent in pig aorta in Group C](cln63_2p0229f2){#f2-cln63_2p0229}

![Macroscopic view of stent in pig aorta in Group M](cln63_2p0229f3){#f3-cln63_2p0229}

![Histological evaluation of aortas in Group C. The intima was thick, showing no endothelial deposits, a well-defined internal elastic lamina and a lack of inflammatory cells (blue arrow)](cln63_2p0229f4){#f4-cln63_2p0229}

![Histological evaluation of aortas in Group M. Modified endothelial cells, with foam macrophages (blue arrow), were present in all specimens. No smooth muscle cells, cholesterol crystals or inflammatory cells were observed at the intima. There was elastic lamina disruption (yellow arrow) and smooth muscle cell hyperplasia, which are both characteristics of homocysteine-induced lesions](cln63_2p0229f5){#f5-cln63_2p0229}

###### 

Intimal thickening statistical analysis

  Group       n   Median   Interquartil range   Min       Max       Average    Standard deviation   *p*
  ----------- --- -------- -------------------- --------- --------- ---------- -------------------- ------------
  Control     7   467,05   422,478              345,644   816,288   545,1983   202,4074             **0,0041**
  Methinine   7   269,32   154,41               131,316   383,154   268,7414   86,6294              

###### 

Total cholesterol levels (mg/dl)

  Time      Group        Median   Interquartíl range   Min   Máx   Average   Standard deviation   *p*
  --------- ------------ -------- -------------------- ----- ----- --------- -------------------- --------
  0 day     Control      86       13                   71    92    82,57     7,66                 0,9015
            methinine    85       6                    63    111   85,86     14,01                
                                                                                                  
  30 days   Control      85       31                   71    120   90,57     17,92                0,6200
            methionine   92       42                   49    101   80,57     22,23                
                                                                                                  
  60 days   Control      106      22                   78    122   103,57    14,76                0,3829
            methionine   92       24                   70    125   96,14     17,58                

###### 

HDL levels (mg/dl)

  time      Group        Median   Interquartil range   Mín   Máx   average   Standard deviation   *p*
  --------- ------------ -------- -------------------- ----- ----- --------- -------------------- --------
  0 day     Control      38       5                    31    45    37,71     4,54                 0,0530
            methionine   42       4                    39    48    42,57     2,94                 
                                                                                                  
  30 days   Control      42       8                    35    52    42,29     5,56                 1
            methionine   48       24                   21    52    40,00     12,94                
                                                                                                  
  60 days   Control      48       17                   32    57    45,57     9,36                 0,2593
                                                                                                  
            methionine   39       9                    33    46    40,43     5,00                 

###### 

Plasma triglyceride levels (mg/dl)

  time      Group        Median   Interquartíl range   Mín   Máx   average   Standard deviation   *p*
  --------- ------------ -------- -------------------- ----- ----- --------- -------------------- --------
  0 day     Control      26       10                   22    34    27,57     4,79                 0,2086
            Methionine   33       15                   21    45    33,71     8,48                 
                                                                                                  
  30 days   Control      33       29                   25    62    38,00     14,85                0,1282
            Methionine   57       68                   19    118   62,29     36,65                
                                                                                                  
  60 days   Control      33       25                   19    75    40,00     18,77                0,0973
            methionine   20       21                   11    60    25,29     17,12                

###### 

Plasma homocysteine levels (μmol/l)

  time      Group        Median   Interquartíl range   Mín    Máx    average   Standard deviation   *p*
  --------- ------------ -------- -------------------- ------ ------ --------- -------------------- ------------
  0 day     Control      13,1     3,2                  12     20     14,40     2,79                 0,3829
            methionine   16,4     10,1                 10     28     17,47     6,14                 
                                                                                                    
  30 days   Control      16,1     5,4                  13     24,2   16,73     3,88                 **0,0006**
            Methionine   56,7     13,7                 45     84,1   59,80     12,64                
                                                                                                    
  60 days   Control      16,2     3,3                  12,3   24,5   16,47     3,98                 0,2086
            methionine   29,3     36,1                 13     54,7   32,74     18,48                
